SCHEMBL1817249

SCHEMBL1817249

CN(C)c1ccc(S(=O)(=O)N2CCOc3ccc(-c4cnc(C#N)nc4)cc32)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 4/20 0.41
▸ PDE3A Q14432 4/20 0.41
▸ CYP2C9 P11712 1/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ RIPK2 O43353 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ LMNA P02545 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ PKLR P30613 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814874 0.90 CYP2C9 (0.38) PDE3BPDE3ACYP2C9NPC1RIPK2
SCHEMBL1816305 0.87 CYP2C9 (0.37) PDE3BPDE3ACYP2C9NPC1MEN1
SCHEMBL1817268 0.86 CYP2C9 (0.53) PDE3BPDE3ACYP2C9NPC1RIPK2
SCHEMBL1817305 0.85 CYP2C9 (0.37) PDE3BPDE3ACYP2C9NPC1MEN1
SCHEMBL1819876 0.85 CCNA2 (0.42) PDE3BPDE3ACYP2C9NPC1RIPK2
SCHEMBL12818264 0.80 PDE3B (0.39) PDE3BPDE3ACYP2C9NPC1RIPK2
SCHEMBL12818233 0.79 PDE3B (0.42) PDE3BPDE3ACYP2C9NPC1RIPK2
SCHEMBL12818485 0.79 PDE3B (0.39) PDE3BPDE3ACYP2C9NPC1RIPK2
SCHEMBL12818373 0.78 SMN1; SMN2 (0.42) PDE3BPDE3ACYP2C9MEN1KMT2A
SCHEMBL1817818 0.77 CYP11B1 (0.45) PDE3BPDE3ACYP2C9NPC1RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback